Cardiovascular and intestinal responses to oxidative and nitrosative stress during prolonged magnesium deficiency

American Journal of the Medical Sciences

Volumn 342, Issue 2, 2011, Pages 125-128

  Weglicki, William B ^a   Chmielinska, Joanna J ^a   Kramer, Jay H ^a   Mak, I Tong ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cardiac and intestinal tissues; Cardiac dysfunction; Hypomagnesemia; Inflammatory oxidative stress; Magnesium deficiency; Neutral endopeptidase; Substance P and substance P receptor blockade; Systemic endotoxemia and endotoxin receptor

Indexed keywords

CD14 ANTIGEN; DIZOCILPINE; ENDOTOXIN; MEMBRANE METALLOENDOPEPTIDASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPEPTIDE; NITRIC OXIDE; PROSTAGLANDIN E2; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SUBSTANCE P; TOLL LIKE RECEPTOR;

CARDIOVASCULAR RESPONSE; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTOXEMIA; EXPERIMENTAL MODEL; HEART; HEART DISEASE; HEART MUSCLE CONTRACTILE FORCE; HUMAN; HYPOMAGNESEMIA; INTESTINE; INTESTINE FUNCTION; LYMPHOCYTIC INFILTRATION; MAGNESIUM DEFICIENCY; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PROTEIN SECRETION; SEIZURE; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UPREGULATION;

EID: 79961026871     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e318222e88c     Document Type: Conference Paper

References (49)

1. Dubey A, Solomon R. Magnesium, myocardial ischaemia and arrhythmias: the role of magnesium in myocardial infarction. Drugs 1989;37: 1-7. (Pubitemid 19050432)
2. Leary WP. Content of magnesium in drinking water and deaths from ischaemic heart disease in white south Africans. Magnesium 1986;5: 150-3.
3. Punsar S, Karvonen MJ. Drinking water quality and sudden death: observations from west and east Finland. J Am Coll Nutr 1985;4:195-206.
4. Anderson TW, Neri LC, Schreiberg HD. Ischaemic heart disease, water hardness and myocardial magnesium. Can Med Assoc J 1975; 113:199-203.
5. Deheinzelin D, Negri EM, Tucci MR, et al. Hypomagnesemia in critically ill cancer patients: a prospective study of predictive factors. Braz J Med Biol Res 2000;33:1443-8. (Pubitemid 33621500)
6. Rubeiz GJ, Thill-Baharozian M, Hardie D, et al. Association of hypomagnesemia and mortality in acutely ill medical patients. Crit Care Med 1993;21:203-9. (Pubitemid 23062833)
7. Riggs JE, Klingberg WG, Flink EB, et al. Cardioskeletal mitochondrial myopathy associated with chronic magnesium deficiency. Neurology 1992;42:128-30.
8. Mantyh PW. Substance P and the inflammatory and immune response. Ann NY Acad Sci 1991;632:263-71.
9. Weglicki WB, Mak IT, Stafford RE, et al. Neurogenic peptides and the cardiomyopathy of Mg-deficiency: effects of substance P-receptor inhibition. Mol Cell Biochem 1994;130:103-9. (Pubitemid 24127581)
10. Weglicki WB, Phillips TM. Pathobiology of magnesium deficiency: a cytokine/neurogenic inflammation hypothesis. Am J Physiol 1992;263: R734-7.
11. Weglicki WB, Mak IT, Phillips TM. Blockade of cardiac inflammation in Mg-deficiency by substance P receptor inhibition. Circ Res 1994;24:1009-13.
12. Furness JB, Costa M, Papka RE, et al. Neuropeptides contained in peripheral cardiovascular nerves. Clin Exp Hypertens A 1984;6:91-106. (Pubitemid 14184493)
13. Weglicki WB, Mak IT, Kramer JH, et al. Role of free radicals and substance P in magnesium deficiency. Cardiovasc Res 1996;31: 677-82. (Pubitemid 26175133)
14. Soma M, Cunnane SC, Horrobin DF, et al. Effects of low magnesium diet on the vascular prostaglandin and fatty acid metabolism in rats. Prostaglandins 1988;36:431-41. (Pubitemid 19009201)
15. Kraeuter SL, Schwartz R. Blood and mast cell histamine levels in magnesium-deficient rats. J Nutr 1980;110:851-8. (Pubitemid 10046105)
16. Classen CU, Abele C, Schimatschek HF, et al. Erythema formation in magnesium-deficient albino rats. A non-invasive model for screening anti-inflammatory agents and oral mineral supplements. Arzneimittelforschung 1993;43:672-5. (Pubitemid 23176493)
17. Brewster DR, Goetzl EJ. Specific stimulation of human T lymphocytes by substance P. J Immunol 1983;131:1613-5. (Pubitemid 13010122)
18. Weglicki WB, Dickens BF, Wagner TL, et al. Immunoregulation by neuropeptides in magnesium deficiency: ex vivo effect of enhanced substance P production on circulating T lymphocytes from Mg-deficient mice. Magnesium Res 1996;9:3-11. (Pubitemid 126478602)
19. Mak IT, Dickens BF, Komarov AM, et al. Activation of the neutrophil and loss of plasma glutathione during Mg-deficiency-modulation effect by NOS inhibition. Mol Cell Biochem 1997;176:35-9. (Pubitemid 27491463)
20. McIntosh TK. Novel pharmacologic therapies in the treatment of experimental traumatic brain injury: a review. J Neurotrauma 1993;10: 215-61. (Pubitemid 23319194)
21. Pierson M, Swann J. Sensitization to noise-mediated induction of seizure susceptibility by MK-801 and phencyclidine. Brain Res 1991; 560:229-36.
22. Miserendino MJ, Davis M. NMDA and non-NMDA antagonists infused into the nucleus reticularis pontis caudalis depress the acoustic startle reflex. Brain Res 1993;623:215-22. (Pubitemid 23275403)
23. Tejero-Taldo MI, Chmielinska JJ, Gonzalez G, et al. N-Methyl-Daspartate receptor blockade inhibits cardiac inflammation in the Mgdeficient rat. J Pharmacol Exp Ther 2004;311:8-13. (Pubitemid 39287778)
24. Kramer JH, Spurney C, Iantorno M, et al. Neurogenic inflammation and cardiac dysfunction due to hypomagnesemia. Am J Med Sci 2009;338:22-7.
25. Kramer JH, Mak IT, Phillips TM, et al. Dietary Mg-intake influence circulating pro-inflammatory neuropeptide levels and loss of myocardial tolerance to postischemic stress. Exp Biol Med 2003;228:665-73. (Pubitemid 37163256)
26. Scholzen TE, Steinhoff M, Bonaccorsi P, et al. Neutral endopeptidase terminates substance-P induced inflammation in allergic contact dermatitis. J Immunol 2001;166:1285-91. (Pubitemid 32060289)
27. Wang L, Sadoun E, Stephens RE, et al. Metabolism of substance P and neurokinin A by human vascular endothelium and smooth muscle. Peptides 1994;15:497-503. (Pubitemid 24223328)
28. Nadel JA. Peptidase modulation of neurogenic inflammation. In: Geppetti P, Holzer P, editors. Neurogenic inflammation. Boca Raton (FL): CRC Press; 1996. p. 115-27.
29. Iwamoto I, Kimura A, Ochiai K, et al. Distribution of NEP activity in human blood leukocytes. J Leuk Biol 1991;49:116-25.
30. Lesser M, Fung K, Choi HS, et al. Identification of two zinc metalloendopeptidases in alveolar macrophages of rats, guinea pigs, and human beings. J Lab Clin Med 1992;120:597-603.
31. Wang DS, Iwata N, Hama E, et al. Oxidized neprilysin in aging and Alzheimer's disease brains. BBRC 2003;310:236-41. (Pubitemid 37162788)
32. Hersh L. Peptidiase, proteases and amyloid beta-peptide catabolism. Curr Pharm Des 2003;9:449-54. (Pubitemid 36131736)
33. Weglicki WB, Mak I-T, Chmielinska JJ, et al. The role of magnesium deficiency in cardiovascular and intestinal inflammation. Magnes Res 2010;23:1-8.
34. Weglicki WB, Chmielinska JJ, Tejero-Taldo MI, et al. Neutral endopeptidase inhibition enhances substance P mediated inflammation due to hypomagnesemia. Magnes Res 2009;22:167S-73S.
35. Zhou M, Arthur AJ, Ba ZF, et al. The small intestine plays an important role in upregulating CGRP during sepsis. Am J Physiol Regul Integr Comp Physiol 2001;280:R382-8.
36. Scanlan BJ, Kim SY, Tuft B, et al. Intestinal inflammation caused by magnesium deficiency alters basal and oxidative stress-induced intestinal function. Mol Cell Biochem 2007;306:59-69. (Pubitemid 350001817)
37. Mak IT, Komarov AM, Wagner TL, et al. Enhanced nitric oxide production during Mg-deficiency and its role in mediating red cell glutathione loss. Am J Physiol 1996;271:C385-90. (Pubitemid 26298815)
38. Fasano A, Shea-Donohue T. Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nature Clinical Practice Gastroenterol Hepatol 2005; 2:416-22. (Pubitemid 41486094)
39. Baumgarten G, Knuefermann P, Nozaki N, et al. In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of toll-like receptor-4. J Infect Dis 2001;183:1617-24. (Pubitemid 32466699)
40. Dickerson C, Undem B, Bullock B, et al. Neuropeptide regulation of proinflammatory cytokine responses. J Leukoc Biol 1998;63:602-5. (Pubitemid 28193773)
41. Comstock KL, Krown KA, Page MT, et al. LPS-induced TNF-alpha release from and apoptosis in rat cardiomyocytes: obligatory role for CD14 in mediating the LPS response. J Mol Cell Cardiol 1998;30: 2761-75. (Pubitemid 29017515)
42. Bolger AP, Anker SD. Tumour necrosis factor in chronic heart failure: a peripheral view on pathogenesis, clinical manifestations and therapeutic implications. Drugs 2000;60:1245-57. (Pubitemid 32039385)
43. Niebauer J, Volk HD, Kemp M, et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 1999;353:1838-42. (Pubitemid 29251016)
44. Kubota T, Miyagishima M, Alvarez RJ, et al. Expression of proinflammatory cytokines in the failing human heart: comparison of recentonset and end-stage congestive heart failure. J Heart Lung Transplant 2000;19:819-24.
45. Li YY, Feng YQ, Kadokami T, et al. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy. Proc Natl Acad Sci USA 2000;97:12746-51.
46. Ferrero E, Jiao D, Tsuberi BZ, et al. Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc Natl Acad Sci USA 1993;90:2380-4. (Pubitemid 23078630)
47. Haziot A, Ferrero E, Kontgen F, et al. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14 deficient mice. Immunity 1996;4:407-14. (Pubitemid 26174055)
48. Chmielinska JJ, Tejero-Taldo MI, Mak IT, et al. Intestinal and cardiac inflammatory response shows enhanced endotoxin receptor (CD14) expression in magnesium deficiency. Mol Cell Biochem 2005; 278:53-7. (Pubitemid 41418918)
49. Kramer JH, Spurney C, Mak I-T, et al. Substance P receptor blockade attenuates oxidative stress, endotoxemia and cardiac dysfunction in Mg-deficient rats (abstract). FASEB J 2011;25:646. 2.